Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae

被引:8
|
作者
Seok, Hyeri [1 ]
Kang, Cheol-In [1 ]
Huh, Kyungmin [1 ]
Cho, Sun Young [1 ]
Ha, Young Eun [1 ]
Chung, Doo Ryeon [1 ]
Peck, Kyong Ran [1 ]
机构
[1] Sungkyunkwan Univ, Div Infect Dis, Dept Med, Samsung Med Ctr,Sch Med, 81 Irwon Ro, Seoul 06531, South Korea
关键词
S; pneumoniae; levofloxacin-nonsusceptible; community-onset pneumonia; risk factor; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; INFECTION; SUSCEPTIBILITIES; PREVALENCE; PATHOGENS; CHILDREN;
D O I
10.1089/mdr.2017.0416
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Fluoroquinolones are antibiotics commonly used in the treatment of infections caused by Streptococcus pneumoniae. However, rates of fluoroquinolone resistance are increasing with their frequent use. We designed this study to verify current fluoroquinolone resistance rates and risk factors for community-onset pneumococcal pneumonia. Methods: A retrospective case-control study was conducted in a tertiary referral hospital. The study population comprised patients admitted for pneumococcal pneumonia between January 2011 and May 2017. The case group included community-onset pneumonia caused by levofloxacin-nonsusceptible S. pneumoniae. The control group consisted of two patients with levofloxacin-susceptible S. pneumoniae who were admitted around the same time as each case. Results: A total of 198 pneumococcal pneumonia cases were identified during the study period. Twenty-five levofloxacin-resistant S. pneumoniae cases and 3 levofloxacin-intermediate S. pneumoniae cases were included in the case group (nonsusceptibility rate=14.1%). Multivariate analysis showed that healthcare-associated factors (odds ratio [OR] 4.78, 95% confidence interval [CI] 1.39-16.43, p=0.013), bronchopulmonary disease (OR 3.79, 95% CI 1.07-13.40, p=0.039), cerebrovascular disease (OR 6.08, 95% CI 1.24-29.75, p=0.026), and exposure to fluoroquinolones within the previous 3 months (OR 5.89, 95% CI 1.21-28.68, p=0.028) were associated with nonsusceptibility to levofloxacin. Conclusion: Independent risk factors for levofloxacin-nonsusceptible pneumococcal pneumonia were recent hospitalization, bronchopulmonary disease, cerebrovascular disease, and prior antibiotic use within 3 months. Careful selection of empirical antibiotics is thus needed in at-risk patients. Similarly, efforts to prevent the interpersonal spread of drug-resistant pathogens in long-term care facilities and to restrict unnecessary fluoroquinolone prescriptions are important.
引用
收藏
页码:1412 / 1416
页数:5
相关论文
共 50 条
  • [21] Epidemiology of community-acquired pneumonia caused by Streptococcus pneumoniae in older adults: a narrative review
    Elias, Christelle
    Nunes, Marta C.
    Saadatian-Elahi, Mitra
    CURRENT OPINION IN INFECTIOUS DISEASES, 2024, 37 (02) : 144 - 153
  • [22] Predictors of drug-resistant pathogens in community-onset pneumonia: Are factors considered in health-care-associated pneumonia useful in the emergency department?
    Torres Bonafonte, Olga H.
    Gil Olivas, Eva
    Perez Macho, Estefania
    Pacho Pacho, Cristina
    Mateo Roca, Miriam
    Casademont Pou, Jordi
    Ruiz Hidalgo, Domingo
    EMERGENCIAS, 2017, 29 (05): : 306 - 312
  • [23] Analysis of clinical characteristics and mortality risk factors in patients with community-acquired pneumonia caused by Klebsiella pneumoniae
    Yu, Xiaofeng
    Suo, Lijun
    Sun, Xiao
    Sun, Tianyu
    Wang, Li
    Qi, Xiaowei
    Hou, Aiming
    Luan, Jiahui
    Wang, Haiyan
    Zhao, Yi
    Liu, Bo
    Cao, Hongyun
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (03)
  • [24] Baicalein exerts a protective role in pneumonia caused by Streptococcus pneumoniae
    Guo Qinghe
    Liu Guangyu
    Liu Xiaobin
    Huang Qingson
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2019, 24 : 849 - 858
  • [25] Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
    Tuzun, Turkan
    Kutlu, Selda Sayin
    Kutlu, Murat
    Kaleli, Ilknur
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2019, 49 (04) : 1206 - 1211
  • [26] Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia
    Webb, Brandon
    Sorensen, Jeffrey
    Mecham, Ian
    Buckel, Whitney
    Ooi, Lilian
    Jephson, Al
    Dean, Nathan
    CHEST, 2019, 156 (05) : 843 - 851
  • [27] Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli
    Kang, Cheol-In
    Song, Jae-Hoon
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Ko, Kwan Soo
    Yeom, Joon-Sup
    Ki, Hyun Kyun
    Son, Jun Seong
    Lee, Seung Soon
    Kim, Yeon-Sook
    Jung, Sook-In
    Kim, Shin-Woo
    Chang, Hyun-Ha
    Ryu, Seong Yeol
    Kwon, Ki Tae
    Lee, Hyuck
    Moon, Chisook
    Shin, Sang Yop
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (03) : 284 - 287
  • [28] Risk Factors for Recurrence of Community-Onset Urinary Tract Infections Caused by Extended-Spectrum Cephalosporin-Resistant Enterobacterales
    Zhang, Helen L.
    Perez, Reinaldo
    Krishnan, Jay
    Lautenbach, Ebbing
    Anderson, Deverick J.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (12):
  • [29] Epidemiology and Clinical Features of Community-Onset Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae
    Lee, Jeong-a
    Kang, Cheol-In
    Joo, Eun-Jeong
    Ha, Young Eun
    Kang, Seung-Ji
    Park, So Yeon
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Ko, Kwan Soo
    Lee, Nam Yong
    Song, Jae-Hoon
    MICROBIAL DRUG RESISTANCE, 2011, 17 (02) : 267 - 273
  • [30] International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
    Aliberti, Stefano
    Cook, Grayden S.
    Babu, Bettina L.
    Reyes, Luis F.
    Rodriguez, Alejandro H.
    Sanz, Francisco
    Soni, Nilam J.
    Anzueto, Antonio
    Faverio, Paola
    Sadud, Ricardo Franco
    Muhammad, Irfan
    Prat, Cristina
    Vendrell, Ester
    Neves, Joao
    Kaimakamis, Evangelos
    Feneley, Andrew
    Swarnakar, Rajesh
    Franzetti, Fabio
    Carugati, Manuela
    Morosi, Manuela
    Monge, Elisa
    Restrepo, Marcos, I
    Karina Aruj, Patricia
    Attorri, Silvia
    Barimboim, Enrique
    Pablo Caeiro, Juan
    Garzon, Maria, I
    Hugo Cambursano, Victor
    Ceccato, Adrian
    Chertcoff, Julio
    Lascar, Florencia
    Di Tulio, Fernando
    Cordon Diaz, Ariel
    de Vedia, Lautaro
    Cristina Ganaha, Maria
    Lambert, Sandra
    Lopardo, Gustavo
    Lopez, Vicente
    Luna, Carlos M.
    Gerardo Malberti, Alessio
    Morcillo, Nora
    Tartara, Silvina
    Pensotti, Claudia
    Pereyra, Betiana
    Gustavo Scapellato, Pablo
    Pablo Stagnaro, Juan
    Shah, Sonali
    Lotsch, Felix
    Thalhammer, Florian
    Anseeuw, Kurt
    JOURNAL OF INFECTION, 2019, 79 (04) : 300 - 311